Form 8-K - Current report:
SEC Accession No. 0001140361-21-016430
Filing Date
2021-05-07
Accepted
2021-05-07 16:01:13
Documents
3
Period of Report
2021-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10024291_8k.htm 8-K 18278
2 EXHIBIT 99.1 brhc10024291_ex99-1.htm EX-99.1 128028
3 image00001.jpg GRAPHIC 3595
  Complete submission text file 0001140361-21-016430.txt   152744
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 21902473
SIC: 2834 Pharmaceutical Preparations